|
Volumn 42, Issue 4, 2013, Pages 267-268
|
Expression of CERS2 in invasive breast cancer tissues and its clinical significance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CERS2 PROTEIN, HUMAN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
MEMBRANE PROTEIN;
SPHINGOSINE ACYLTRANSFERASE;
TUMOR SUPPRESSOR PROTEIN;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CELL STRAIN MCF 7;
COLLOID CARCINOMA;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG CARCINOMA;
LYMPH NODE METASTASIS;
MASTECTOMY;
METABOLISM;
MIDDLE AGED;
PAGET NIPPLE DISEASE;
PATHOLOGY;
SURVIVAL RATE;
ADENOCARCINOMA, MUCINOUS;
ADULT;
AGED;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
CARCINOMA, LOBULAR;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LYMPHATIC METASTASIS;
MASTECTOMY, MODIFIED RADICAL;
MCF-7 CELLS;
MEMBRANE PROTEINS;
MIDDLE AGED;
RECEPTOR, ERBB-2;
SPHINGOSINE N-ACYLTRANSFERASE;
SURVIVAL RATE;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 84878626267
PISSN: 05295807
EISSN: None
Source Type: Journal
DOI: 10.3760/cma.j.issn.0529-5807.2013.04.012 Document Type: Article |
Times cited : (4)
|
References (3)
|